Preferred Name |
Amprenavir |
|
Synonyms |
Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(- phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))- 141W94 AMPRENAVIR Agenerase Amprenavir KVX 478 VX 478 |
|
Definitions |
A synthetic derivative of hydroxyethylamine sulfonamide that selectively binds to and inhibits human immunodeficiency virus (HIV) protease. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28824 |
|
CAS_Registry |
161814-49-9 |
|
CHEBI_ID |
CHEBI:40050 |
|
Chemical_Formula |
C25H35N3O6S |
|
code |
C28824 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A synthetic derivative of hydroxyethylamine sulfonamide that selectively binds to and inhibits human immunodeficiency virus (HIV) protease. |
|
FDA_UNII_Code |
5S0W860XNR |
|
FULL_SYN |
Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(- phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))- 141W94 AMPRENAVIR Agenerase Amprenavir KVX 478 VX 478 |
|
label |
Amprenavir |
|
Legacy Concept Name |
Amprenavir |
|
Preferred_Name |
Amprenavir |
|
prefixIRI |
Thesaurus:C28824 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0754188 |
|
subClassOf |